Mary K. Pitner, Ph.D.
Affiliations: | 2013 | Biological and Biomedical Sciences | Emory University, Atlanta, GA |
Area:
Genetics, Molecular Biology, Cell Biology, OncologyGoogle:
"Mary Pitner"Parents
Sign in to add mentor| Harold Saavedra | grad student | 2013 | Emory | |
| (The Role of Cdk4 in Her2 Driven Centrosome Amplification.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Xie X, Chauhan GB, Edupuganti R, et al. (2024) Correction: Maternal Embryonic Leucine Zipper Kinase Is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Research Communications. 4: 236 |
| Xie X, Chauhan GB, Edupuganti R, et al. (2023) Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Research Communications. 3: 1078-1092 |
| Gagliardi M, Pitner MK, Park J, et al. (2020) Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer. Scientific Reports. 10: 8537 |
| Gagliardi M, Chauhan G, Pitner M, et al. (2019) Abstract P5-03-06: Overcoming MEK inhibitor resistance in triple-negative breast cancer by targeting myeloid cell leukemia-1 (MCL1), an anti-apoptotic protein Cancer Research. 79 |
| Pitner MK, Taliaferro JM, Dalby KN, et al. (2017) MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies. Expert Opinion On Therapeutic Targets. 1-11 |
| Battula VL, Nguyen K, Sun J, et al. (2017) IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells. Oncotarget |
| Torres-Adorno A, Lee J, Kogawa T, et al. (2016) Abstract P5-04-02: The histone deacetylase inhibitor entinostat enhances the efficacy of the MEK inhibitor pimasertib against aggressive types of breast cancer through Noxa-mediated myeloid cell leukemia 1 degradation Cancer Research. 76 |
| Pitner MK, Saso H, Larson R, et al. (2016) Abstract 1624: Silencing of ERK2 reverses EMT and suppresses the CSC phenotype, inhibiting lung metastasis in triple-negative breast cancer Cancer Research. 76: 1624-1624 |
| Kai K, Kondo K, Wang X, et al. (2015) Antitumor Activity of KW-2450 Against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases. Molecular Cancer Therapeutics |
| Bartholomeusz C, Xie X, Pitner MK, et al. (2015) MEK inhibitor selumetinib (AZD6244; ARRY-142886) prevents lung metastasis in a triple-negative breast cancer xenograft model. Molecular Cancer Therapeutics |